Publications
Publications
Show Results For
- All HBS Web
(1,124)
- Faculty Publications (257)
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details
- June 1991 (Revised December 1998)
- Teaching Note
Corning Glass Works International (A), (B1), and (B2), Teaching Note
By: David J. Collis
Teaching Note for (9-381-160), (9-381-161), and (9-381-162). View Details
- January 1991 (Revised March 1991)
- Case
Responsible Care
By: George C. Lodge and Jeffrey F. Rayport
Describes a 1989 initiative of the Chemical Manufacturer's Association (CMA) to secure chemical industry support for and implementation of a series of codes of conduct in the field of environmental health and safety. Called "Responsible Care", the program makes... View Details
- October 1990 (Revised April 1991)
- Case
RU 486 (A)
Describes the factors faced by Roussel UCLAF, a French drug company, in deciding whether and how to market a controversial new drug, RU 486, which is often called "the French abortion pill." Roussel's decision involved its relations with the French government, its... View Details
- 16 Jun 1990
- Lecture
Dainippon Ink and Chemicals Co., Inc
By: W. Carl Kester
Keywords: Chemical Industry
- June 1990 (Revised April 1993)
- Teaching Note
Novo Industri A/S--1981, Teaching Note
By: W. Carl Kester
Teaching Note for (9-286-084). View Details
- February 1990 (Revised March 1990)
- Case
Quantum Semiconductor, Inc.
By: Janice H. Hammond and Roy D. Shapiro
Quantum is faced with a difficult ethical dilemma--industry studies provide evidence that chemicals used in semiconductor manufacturing may cause women working in fabrication cleanrooms to suffer a higher likelihood of spontaneous abortions. The possibility of other... View Details
Keywords: Safety; Prejudice and Bias; Law; Equality and Inequality; Cost; Production; Ethics; Health; Gender; Semiconductor Industry
- January 1990 (Revised October 1993)
- Case
Monsanto's March into Biotechnology (A)
By: Gary P. Pisano
Very early in the history of biotechnology (about 1979), Monsanto made a major commitment to move into this field. This case recounts the history from the point of view of the eminent scientist hired to head up corporate R&D. He took Monsanto from a very traditional... View Details
- June 1988 (Revised February 1989)
- Case
Union Carbide Deal, The
By: Dwight B. Crane and Robert G. Eccles Jr.
Keywords: Chemical Industry
- February 1987 (Revised October 1989)
- Teaching Note
Rohm and Haas (A): New Product Marketing Strategy, Teaching Note
Teaching Note for (9-587-055). View Details
Keywords: Chemical Industry
- February 1987 (Revised February 2000)
- Case
Polysar Limited
By: Robert L. Simons
Canada's largest chemical company produces and markets butyl rubber in two divisions, each treated as a profit center. The new plant in the North American Division operates below capacity resulting in a significant volume variance and an operating loss. The European... View Details
- September 1986 (Revised February 2007)
- Case
Solagen: Process Improvement in the Manufacture of Gelatin at Kodak
By: Dorothy A. Leonard and Brian DeLacey
Kodak must decide whether to make a major investment in a production facility designed around a new technique for producing the gelatin critical to so many film and paper products. Currently, gelatin making is an arcane art, unchanged in 150 years and heavily dependent... View Details
- February 1986
- Supplement
Kedaung Industrial Ltd., Video
Presents an interview with the Indonesian partner of Corning Glass Works' investment in Indonesia. The first part of the interview sets out the original decisions made by the partners. It serves to introduce the partners to the class and to help them decide whether to... View Details
- February 1986 (Revised November 1992)
- Case
Novo Industri A/S--1981
By: W. Carl Kester and Glynn Ferguson
This small but rapidly growing Danish biochemical company must choose among several financing opportunities that include a convertible Eurobond, a rights offering in Denmark and an issue of new common shares in the United States. The case involves a broad range of... View Details
- July 1985 (Revised February 1986)
- Case
Dow Indonesia (B1)
By: James E. Austin, Dennis J. Encarnation III and Louis T. Wells Jr.
- July 1985 (Revised January 1990)
- Case
Dow Indonesia (B2)
By: James E. Austin, Dennis J. Encarnation III and Louis T. Wells Jr.
- July 1985 (Revised February 1986)
- Case
Dow Indonesia (A)
By: James E. Austin, Dennis J. Encarnation III and Louis T. Wells Jr.